PaTcH Study: A Phase 2 Study of Trametinib and Hydroxychloroquine in Patients With Metastatic Refractory Pancreatic Cancer

Condition:   Pancreatic Cancer Interventions:   Drug: Trametinib;   Drug: Hydroxychloroquine Sponsors:   Cancer Trials Ireland;   Novartis Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials